Another Push for Upfront Ezetimibe-Statin Combo Soon After MI
Swedish study suggests more MACE with delayed addition of ezetimibe to statins after heart attack
Related Articles
Registry Data Rekindle Talk Over the Best Valve for TAVI in Small Annuli
As in the SMART trial, early hemodynamic differences have yet to result in a clinical impact—but it may just be a matter of time.
Routine Antibiotics Appear to Hold No Benefit in Non-Severe COVID-19
In retrospective study, hospitalized patients who got antibiotics seemed to do slightly worse
Biden Has Reason for Optimism, Despite Advanced Prostate Cancer Diagnosis
Improved treatment allows many men to live longer with good quality of life, experts say
Study Underscores Detrimental Impact of Insurance Policies on Both the Mental and Physical Health of Patients
The examines the experiences of 22 female patients in West Virginia whose insurance provider discontinued coverage for anti-obesity medications. Through semi-structured interviews, the study reveals…
Suicide Top Cause of Death for Residents, Especially During Transition Periods
Highest number of suicides occurred during the first academic quarter of first residency year
What Does Persistently Active Disease Mean for Patients?
Systemic lupus erythematosus (SLE) is a highly unpredictable disease characterized by significant variability between patients, which makes both prediction and management particularly challenging. In a…
H5N1 Bird Flu Cases Have Slowed in Animals and People
However, CDC researchers recommend continued surveillance
FDA Clears First Blood Test for Alzheimer’s Diagnosis
Plasma assessment is not intended as a screening or stand-alone diagnostic test, agency says
Acute Severe Ulcerative Colitis: An International Delphi Consensus on Clinical Trial Design and Endpoints
Interventional clinical trials in acute severe ulcerative colitis (ASUC) are characterized by substantial heterogeneity due to a lack of consensus in several key areas of…